Goldman Sachs Group Inc Glycomimetics Inc Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Glycomimetics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 804,342 shares of GLYC stock, worth $337,823. This represents 0.0% of its overall portfolio holdings.

Number of Shares

804,342

Previous 1,114,708 27.84%

Holding current value

$337,823

Previous $3.34 Million 93.27%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.24 - $3.04 $74,487 - $943,512	-310,366 Reduced 27.84%	804,342 $225,000
Q1 2024 May 15, 2024	BUY	$2.55 - $3.49 $498,150 - $681,781	195,353 Added 21.25%	1,114,708 $3.34 Million
Q4 2023 Feb 13, 2024	BUY	$1.13 - $2.54 $141,092 - $317,146	124,861 Added 15.72%	919,355 $2.17 Million
Q3 2023 May 14, 2024	SELL	$1.29 - $1.73 $161,070 - $216,009	-124,861 Reduced 13.58%	794,494 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$1.29 - $1.73 $13,884 - $18,619	10,763 Added 1.37%	794,494 $1.19 Million
Q2 2023 May 14, 2024	SELL	$1.21 - $2.08 $142,973 - $245,772	-118,160 Reduced 13.1%	783,731 $1.36 Million
Q2 2023 Aug 14, 2023	SELL	$1.21 - $2.08 $142,973 - $245,772	-118,160 Reduced 13.1%	783,731 $1.36 Million
Q1 2023 May 14, 2024	BUY	$1.25 - $4.05 $1.04 Million - $3.38 Million	834,220 Added 1232.76%	901,891 $1.14 Million
Q1 2023 May 11, 2023	BUY	$1.25 - $4.05 $1.04 Million - $3.38 Million	834,220 Added 1232.76%	901,891 $1.14 Million
Q4 2022 May 14, 2024	SELL	$0.57 - $3.03 $485,459 - $2.58 Million	-851,684 Reduced 92.64%	67,671 $205,000
Q4 2022 Feb 13, 2023	BUY	$0.57 - $3.03 $38,572 - $205,043	67,671 New	67,671 $205,000
Q1 2022 May 16, 2022	SELL	$1.0 - $1.58 $38,533 - $60,882	-38,533 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.14 $17,507 - $26,018	12,158 Added 46.1%	38,533 $55,000
Q3 2021 Nov 10, 2021	BUY	$1.8 - $2.39 $47,475 - $63,036	26,375 New	26,375 $58,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

25.7M

Call Options Held

1.94M

Put Options Held

153K

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $22M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Glycomimetics Inc Transaction History